MRIs can’t detect every prostate cancer
Every year around 5,000 Norwegian men are diagnosed with prostate cancer. A new diagnostic procedure using magnetic resonance imaging (MRI) is in use, but to date it is too unreliable to use on its own.
A Norwegian technology for delivering cancer-fighting medications to targeted parts of the body is showing promising results. The technology has been used on cancers in the head and neck region and will now be tried out on cancer of the bile duct.